Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Am J Transplant. 2013 May 1;13(6):1523–1532. doi: 10.1111/ajt.12234

Table 5.

Multivariate associations of plasma cell neoplasm risk.

Characteristic Adjusted SIR ratio 95% lower limit 95% upper limit P-value
Multivariate model
Male sex 1.14 0.74 1.77 0.54
Age at transplant, years 0.002*
 0–34 4.02 1.45 11.14
 35–49 1.58 0.98 2.54
 50–64 1.00
 65+ 0.75 0.44 1.28
Race/ethnicity 0.06
 White 1.00
 Black 0.53 0.30 0.92
 Hispanic 0.72 0.37 1.39
 Asian/Pacific Islander 1.46 0.59 3.63
EBV serology 0.04
 Positive 1.00
 Negative 2.76 1.26 6.06
 Missing 1.00 0.61 1.66
BMI 0.07*
 Underweight 0.29 0.04 2.08
 Normal weight 1.00
 Overweight 0.64 0.41 0.99
 Obese 0.58 0.33 1.02
Models adjusted for sex and age
Cholestatic liver disease, liver recipients 3.12 1.27 7.69 0.02
Coronary artery disease, heart recipients 0.48 0.22 1.05 0.07
Monoclonal antibody (plasmacytoma) 3.32 1.51 7.28 0.008
MMF (plasmacytoma) 0.42 0.20 0.87 0.01

Notes

Abbreviations: BMI body mass index, EBV Epstein-Barr virus, MMF mycophenolate mofetil, SIR standardized incidence ratio.

*

P-value is for test of trend. Other p-values are tests of heterogeneity.